药品回扣的违法性判断  

On the Judgment of the Illegality of Drug Rebate

作　　者：陈雪 刘毅 Chen Xue;Liu Yi

机构地区：[1]西南医科大学法学院 [2]西南医科大学

出　　处：《医学与法学》2019年第2期12-16,共5页Medicine and Jurisprudence

基　　金：2013年泸州医学院(现西南医科大学)课题"TRIPS协议下我国药品实验数据的保护制度研究"的阶段性成果

摘　　要：药品回扣和其他商业贿赂一样,是一种不正当竞争行为;而药品是一种特殊的商品,更应当有特别的法律对其作出规范。药品回扣有明扣和暗扣之分,应区别对待:药品的明扣经历了由违法犯罪化到除罪合法化的过程,在合法与非法、出入罪的选择中,不应合法化,但应坚持出罪;而对暗扣应当坚持采用包括刑事手段在内的措施严厉打击。Drug rebate, like other commercial bribery, is an act of unfair competition, while drug is a special commodity, and it should be regulated by special laws. Drug rebates are divided into open deduction and hidden deduction and should be treated differently. Open rebate has gone through the process from illegal crime to decriminalization. In the choice between legal and illegal crimes, decriminalization and criminalization, drug rebate should not be legalized, but should not be criminalized. Andhidden rebate should be cracked down severely by taking measures including criminal measures.

关 键 词：药品回扣 商业贿赂 药品明扣 药品暗扣 

分 类 号：D924.3[政治法律—刑法学] D922.16[政治法律—法学] R-05[医药卫生]